# Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids

> **NCT00205712** · PHASE4 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 40 (actual)

## Conditions studied

- Psychoses, Substance-Induced

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT00205712
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00205712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00205712, "Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00205712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*